Assessment of biomarker stability and assay performance parameters for medical diagnosis: a case study of diagnosis of major depressive disorder

Mike Jentsch*, Barry van der Strate, Marjolein Meddens, Marcus Meddens, Robert Schoevers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Aim: Assessing the stability profiles and assay performance of 24 biomarker assays in 32 biomarker/body fluid combinations identified as relevant for prediction of major depressive disorder. Materials & methods: Combinations were tested for stability and assay performance with ELISA at different storage and freeze–thaw conditions in pooled samples of 40 patients. Results: Stability and assay performance issues were found in almost all cases except three biomarkers in urine and three in serum. Conclusion: This study shows that, to produce reliable measurement data, assessments of stability and assay performance are essential. In development, other quality assurance parameters might be implemented to increase the level of measurement reliability by increasing assay performance control.

Original languageEnglish
Pages (from-to)59-68
Number of pages10
JournalBiomarkers in medicine
Volume18
Issue number2
DOIs
Publication statusPublished - 2024

Keywords

  • biomarkers
  • ELISA
  • major depressive disorder
  • method development
  • quality assurance
  • stability

Fingerprint

Dive into the research topics of 'Assessment of biomarker stability and assay performance parameters for medical diagnosis: a case study of diagnosis of major depressive disorder'. Together they form a unique fingerprint.

Cite this